StepStone Group’s Asensus Surgical, Inc. ASXC Stock Holding History

StepStone Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-233,279	Closed	-$5.16M	–	7
2018 Q1	$5.16M	Hold	233,279	–	–	3.79%	4
2017 Q4	$5.85M	Hold	233,279	–	–	4.08%	4
2017 Q3	$4.34M	Hold	233,279	–	–	2.87%	4
2017 Q2	$2.15M	Hold	233,279	–	–	1.31%	7
2017 Q1	$3.67M	Hold	233,279	–	–	4.05%	6
2016 Q4	$3.94M	Hold	233,279	–	–	4.78%	6
2016 Q3	$5.13M	Hold	233,279	–	–	6.37%	5
2016 Q2	$3.7M	Sell	233,279 -34,453	-13%	-$1.08M	4.59%	8
2016 Q1	$14.8M	Hold	267,732	–	–	20.58%	2
2015 Q4	$8.63M	Hold	267,732	–	–	22.57%	3
2015 Q3	$7.87M	Hold	267,732	–	–	3.7%	4
2015 Q2	$10.4M	Hold	267,732	–	–	4.31%	3
2015 Q1	$10.2M	Hold	267,732	–	–	2.91%	4
2014 Q4	$10.1M	Hold	267,732	–	–	2.31%	5
2014 Q3	$15.2M	Hold	267,732	–	–	3.56%	5
2014 Q2	$17.5M	Buy	+267,732	New	+$15.5M	13.67%	4

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GXMC

Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

StepStone Group's ASXC Position: Q2 2018 in Review

StepStone Group sold out of Asensus Surgical, Inc. (ASXC) in Q2 2018, closing a stake of 233,279 shares — an estimated $5.16M sold.

StepStone Group first reported a position in ASXC in Q2 2014 and held it in 16 quarters. The position peaked at $17.5M in Q2 2014. 132 funds tracked by Wall St. Rank hold ASXC as of Q2 2018.

StepStone Group reported no remaining Asensus Surgical, Inc. position as of Q2 2018 after selling out during the quarter.
StepStone Group sold 233,279 Asensus Surgical, Inc. shares in Q2 2018, an estimated $5.16M.
StepStone Group first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 16 quarters.
StepStone Group's Asensus Surgical, Inc. position peaked at $17.5M in Q2 2014.
132 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2018.

Based on StepStone Group's 13F filing for Q2 2018, filed 13 Aug 2018.